SAM in Cardiology

Introduction

Systolic Anterior Motion (SAM) is a condition affecting the heart's mitral valve and left ventricle. It is most commonly seen in patients with Hypertrophic Cardiomyopathy (HCM) , where the mitral valve's leaflets move abnormally toward the septum during systole (heart contraction). This can lead to left ventricular outflow tract (LVOT) obstruction , reducing blood flow from the heart.

Causes and Risk Factors

  • Hypertrophic Cardiomyopathy (HCM) – The most frequent cause.
  • Structural abnormalities of the mitral valve – Elongated valve leaflets can contribute to SAM.
  • Hyperdynamic circulatory states – Conditions like dehydration or high-stress states.
  • Post-surgical or congenital heart conditions .

Symptoms

Patients with SAM often experience: - Shortness of breath (dyspnea) - Chest pain - Dizziness or fainting (syncope) - Palpitations (irregular heartbeats)

Diagnosis

  • Echocardiography (especially Doppler imaging) to visualize abnormal mitral valve movement.
  • Cardiac MRI to evaluate heart structure.
  • Electrocardiogram (ECG) to detect associated arrhythmias.

Treatment Options

1. Medications

  • Beta-blockers (e.g., metoprolol) – Reduce heart contraction force, decreasing SAM severity.
  • Calcium channel blockers (e.g., verapamil) – Relax the heart muscle.
  • Avoidance of diuretics – These may exacerbate obstruction.

2. Surgical & Interventional Procedures

  • Septal Myectomy – Surgical removal of excess ventricular muscle to reduce obstruction.
  • Alcohol Septal Ablation (ASA) – A less invasive procedure to reduce thickened heart muscle.
  • Mitral Valve Surgery – In severe cases, mitral valve repair or replacement may be needed.

3. Lifestyle Modifications

  • Avoid dehydration and excessive alcohol.
  • Be cautious with intense exercise; consult a cardiologist before engaging in high-level sports.

Conclusion

SAM is a serious cardiac condition that requires timely diagnosis and management, often linked to Hypertrophic Cardiomyopathy. With proper treatment, many patients can lead active and fulfilling lives.

Source recommendations

1. 2023 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy

  1. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250
  2. https://www.jacc.org/doi/10.1016/j.jacc.2024.04.002
  3. https://pubmed.ncbi.nlm.nih.gov/38718139/
  4. https://www.jacc.org/guidelines/hcm
  5. https://professional.heart.org/en/science-news/2024-guideline-for-the-management-of-hypertrophic-cardiomyopathy

2. 2024 ESC Guidelines on Hypertrophic Cardiomyopathy

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Cardiomyopathy-Guidelines
  2. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250
  3. https://www.jacc.org/doi/10.1016/j.jacc.2024.04.002
  4. https://academic.oup.com/eurheartj/article/45/Supplement_1/ehae666.2024/7836969
  5. https://pubmed.ncbi.nlm.nih.gov/39520615/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow